INVO Bioscience Acquires NAYA Biosciences in All-Stock Merger
October 14, 2024
INVO Bioscience and NAYA Biosciences entered into a definitive all-stock merger agreement under which INVO would acquire 100% of NAYA in a reverse triangular merger. The combined company operates as NAYA Biosciences and trades on NASDAQ under the “NAYA” ticker after closing.
- Buyers
- INVO Bioscience
- Targets
- NAYA Biosciences
- Industry
- Healthcare Services
- Location
- Florida, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
INVO Bioscience Acquires Wisconsin Fertility Institute
March 20, 2023
Healthcare Services
INVO Bioscience, Inc. (Nasdaq: INVO) has signed binding agreements to acquire Wisconsin Fertility Institute, a Madison-area fertility clinic that generated approximately $5.5 million in trailing 12-month revenue. The purchase price is $10.0 million payable over three years, and the clinic will become a wholly owned subsidiary to expand INVO's clinic footprint and support adoption of its INVOcell technology.
-
EPAM Systems Acquires NAYA Technologies (and US subsidiary NAYA Tech)
November 5, 2019
IT Services
EPAM Systems has acquired NAYA Technologies, an Israel-headquartered consultancy, and its US subsidiary NAYA Tech (San Jose, CA) to strengthen EPAM's cloud migration, data management and database migration capabilities, including the migVisor automated migration assessment tool. The acquisition augments EPAM's technology consulting practice and accelerates its ability to deliver end-to-end cloud and data services to enterprise clients.
-
USANA Health Sciences Acquires 78.8% Stake in Hiya Health
December 23, 2024
Consumer Products
USANA Health Sciences acquired a 78.8% controlling stake in Hiya Health Products, LLC for approximately $205 million in cash, closing December 23, 2024. The acquisition expands USANA's direct-to-consumer presence in the children's health and wellness market and is expected to be accretive to USANA's 2025 adjusted EBITDA.
-
Asahi Kasei Medical to Acquire Bionova Scientific
April 14, 2022
Healthcare Services
Asahi Kasei Medical, through a U.S. subsidiary, has agreed to wholly acquire Bionova Scientific, LLC, a U.S.-based biopharmaceutical CDMO providing contract process development and GMP-compliant contract manufacturing services. The acquisition will add CDMO capabilities to Asahi Kasei Medical’s existing bioprocess business and broaden know-how-driven services for next-generation antibody drugs.
-
Nuvei Acquires Paya for $1.3 Billion
January 9, 2023
Payments & Fintech
Nuvei Corporation agreed to acquire Paya Holdings Inc. in an all-cash transaction valued at approximately $1.3 billion (USD $9.75 per share). The deal combines Nuvei's global payment platform with Paya's U.S. integrated-payments and ISV capabilities to accelerate growth in eCommerce, integrated payments and B2B end markets.
-
Envista Acquires Osteogenics Biomedical Business
May 17, 2022
Medical Devices
Envista Holdings Corporation entered into a definitive agreement to acquire Osteogenics Biomedical, Allotech LLC and OBI Biologics (collectively “Osteogenics”), a developer of regenerative dental bone grafting products sold primarily under the Cytoplast brand. The deal, subject to customary regulatory approvals and expected to close in the third quarter, expands Envista’s capabilities in regenerative solutions for periodontists, oral and maxillofacial surgeons and implant dentistry; the transaction is not subject to a financing condition or shareholder vote.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.